6-[(2S)-2-methyl-4-[3-(4-oxo-4aH-quinazolin-2-yl)propanoyl]piperazin-1-yl]pyridine-3-carbonitrile
C22H22N6O2 — CID 162370444
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-[(2S)-2-methyl-4-[3-(4-oxo-4aH-quinazolin-2-yl)propanoyl]piperazin-1-yl]pyridine-3-carbonitrile
6-[(2S)-2-methyl-4-[3-(4-oxo-4aH-quinazolin-2-yl)propanoyl]piperazin-1-yl]pyridine-3-carbonitrile (PubChem CID 162370444) has the molecular formula C22H22N6O2 and a molecular weight of 402.46 g/mol. Its IUPAC name is 6-[(2S)-2-methyl-4-[3-(4-oxo-4aH-quinazolin-2-yl)propanoyl]piperazin-1-yl]pyridine-3-carbonitrile.
Molecular Properties
| Compound Name | 6-[(2S)-2-methyl-4-[3-(4-oxo-4aH-quinazolin-2-yl)propanoyl]piperazin-1-yl]pyridine-3-carbonitrile |
|---|---|
| PubChem CID | 162370444 |
| Molecular Formula | C22H22N6O2 |
| Molecular Weight | 402.46 g/mol |
| Exact Mass | 402.18 |
| IUPAC Name | 6-[(2S)-2-methyl-4-[3-(4-oxo-4aH-quinazolin-2-yl)propanoyl]piperazin-1-yl]pyridine-3-carbonitrile |
| SMILES | C[C@H]1CN(C(=O)CCC2=NC(=O)C3C=CC=CC3=N2)CCN1c1ccc(C#N)cn1 |
| InChI | InChI=1S/C22H22N6O2/c1-15-14-27(10-11-28(15)20-8-6-16(12-23)13-24-20)21(29)9-7-19-25-18-5-3-2-4-17(18)22(30)26-19/h2-6,8,13,15,17H,7,9-11,14H2,1H3/t15-,17?/m0/s1 |
| InChIKey | ZKDROXCCRKJCLM-MYJWUSKBSA-N |
| XLogP | 1.89 |
| TPSA | 102.02 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 402.46 |
| LogP ≤ 5 | 1.89 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 162370444 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.